Learn More
MP Biomedicals™ Recombinant SARS-CoV-2 Spike S (B.1.1.529/Omicron) Trimer Protein (His tag)
Shop All MP Biomedicals, Inc ProductsDescription
MP Biomedicals recombinant SARS-CoV-2 Spike S (B.1.1.529/Omicron) Trimer Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Val16-Glu1213) of SARS-CoV-2 Spike S (B.1.1.529/Omicron) (Accession #QHO60594.1) fused with His tag at the C-terminal.
- Eukaryotic (Expi293) system-expressed protein
- High bioactivity determined with ELISA
- High purity determined with SDS-PAGE
Specifications
Specifications
| Concentration | 1 mg/mL if dissolve in 100 μL of ddH20 or biological buffer |
| For Use With (Application) | Binding Assay, ELISA, Immune Blocking, Immunoprecipitation, SDS-PAGE, Surface Plasmon Resonance (SPR), Western Blot |
| Formulation | Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.3 to 7.4. |
| Preparation Method | Affinity Chromatography |
| Quantity | 100 μg |
| Regulatory Status | RUO |
| Endotoxin Concentration | < 1 EU/μg of the protein by LAL method |
| Gene Alias | S1 protein; Spike glycoprotein subunit1; Omicron variant S1 protein |
| Conjugate | Unconjugated |
| Species | SARS-CoV-2 |
| Show More |
For research or further manufacturing use only, not for direct human use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.